Holdings (Monthly)
Guide ↗
iShares Neuroscience and Healthcare ETF
· iShares Trust| # | Name | Ticker | Since | Shares | Shares Δ | Value | Val Δ% | % Port | Cat |
|---|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares | 066922519 | Apr 2024 | 802,707 | +152,629 | $803K | +23.5% | 14.64% | STIV |
| 2 | Dianthus Therapeutics Inc | 252828108 | Apr 2024 | 2,739 | +486 | $293K | +143.5% | 5.34% | EC |
| 3 | Xenon Pharmaceuticals Inc | 98420N105 | Apr 2024 | 4,264 | -43 | $267K | +51.3% | 4.87% | EC |
| 4 | Praxis Precision Medicines Inc | 74006W207 | Jan 2026 | 868 | +86 | $267K | +8.8% | 4.87% | EC |
| 5 | ACADIA PHARMACEUTICALS INC. | 004225108 | Apr 2024 | 9,949 | +2,884 | $257K | +45.0% | 4.69% | EC |
| 6 | ARROWHEAD PHARMACEUTICALS, INC. | 04280A100 | Jul 2026 | 3,016 | NEW | $255K | — | 4.65% | EC |
| 7 | ALKERMES PUBLIC LIMITED COMPANY | G01767105 | Jan 2026 | 5,153 | -1,415 | $252K | +13.4% | 4.60% | EC |
| 8 | Scholar Rock Holding Corp | 80706P103 | Apr 2024 | 4,979 | +673 | $235K | +23.3% | 4.29% | EC |
| 9 | BIOGEN INC. | 09062X103 | Apr 2024 | 1,129 | +60 | $229K | +19.2% | 4.18% | EC |
| 10 | NEUROCRINE BIOSCIENCES, INC. | 64125C109 | Apr 2024 | 1,345 | +98 | $224K | +32.2% | 4.09% | EC |
| 11 | argenx SE | 04016X101 | Apr 2024 | 248 | +33 | $212K | +17.2% | 3.86% | — |
| 12 | PTC THERAPEUTICS, INC. | 69366J200 | Apr 2024 | 3,109 | +599 | $211K | +11.5% | 3.85% | EC |
| 13 | AXSOME THERAPEUTICS, INC. | 05464T104 | Jan 2026 | 949 | -350 | $207K | -13.6% | 3.77% | EC |
| 14 | Denali Therapeutics Inc | 24823R105 | Jan 2026 | 8,750 | +412 | $201K | +11.1% | 3.67% | EC |
| 15 | Dyne Therapeutics, Inc | 26818M108 | Apr 2024 | 7,764 | +1,031 | $195K | +62.3% | 3.56% | EC |
| 16 | Edgewise Therapeutics Inc | 28036F105 | Apr 2024 | 4,615 | -282 | $177K | +28.7% | 3.23% | EC |
| 17 | SUPERNUS PHARMACEUTICALS, INC. | 868459108 | Apr 2024 | 3,202 | -291 | $143K | -15.1% | 2.61% | EC |
| 18 | AxoGen, Inc. | 05463X106 | Apr 2024 | 3,041 | +156 | $128K | +27.7% | 2.34% | EC |
| 19 | SK Biopharmaceuticals Co Ltd | Y806MN108 | Jan 2026 | 2,295 | +494 | $126K | -14.2% | 2.30% | EC |
| 20 | H. LUNDBECK A/S | N/A | Jan 2026 | 15,754 | +14,436 | $101K | +186.0% | 1.84% | EC |
| 21 | Biohaven Ltd | G1110E107 | Jan 2026 | 7,377 | +440 | $100K | +21.4% | 1.82% | EC |
| 22 | SAREPTA THERAPEUTICS, INC. | 803607100 | Apr 2024 | 5,954 | -382 | $88K | -31.3% | 1.61% | EC |
| 23 | BioArctic AB | N/A | Jan 2026 | 2,506 | NEW | $86K | — | 1.56% | EC |
| 24 | Taysha Gene Therapies Inc | 877619106 | Jan 2026 | 13,999 | -327 | $82K | +27.0% | 1.50% | EC |
| 25 | Neuren Pharmaceuticals Ltd | N/A | Jan 2026 | 6,435 | NEW | $81K | — | 1.48% | EC |
| 26 | Idorsia Ltd | N/A | Jan 2026 | 10,423 | NEW | $79K | — | 1.44% | EC |
| 27 | Rapport Therapeutics Inc | 75383L102 | Jan 2026 | 1,673 | -131 | $69K | +42.8% | 1.25% | EC |
| 28 | INTEGRA LIFESCIENCES HOLDINGS CORPORATION | 457985208 | Apr 2024 | 3,915 | -312 | $65K | +38.4% | 1.19% | EC |
| 29 | Alto Neuroscience Inc | 02157Q109 | Jul 2026 | 1,846 | NEW | $50K | — | 0.91% | EC |
| 30 | LB Pharmaceuticals Inc | 50180M108 | Jul 2026 | 1,221 | NEW | $49K | — | 0.89% | EC |
| 31 | Dynavox Group AB | N/A | Jan 2026 | 5,818 | NEW | $44K | — | 0.80% | EC |
| 32 | Annexon Inc | 03589W102 | Apr 2024 | 8,380 | +493 | $43K | -13.2% | 0.78% | EC |
| 33 | Medincell SA | N/A | Jan 2026 | 1,372 | NEW | $41K | — | 0.75% | EC |
| 34 | Solid Biosciences Inc | 83422E204 | Apr 2024 | 4,599 | +882 | $37K | +54.4% | 0.68% | EC |
| 35 | Bright Minds Biosciences Inc | 10919W405 | Jan 2026 | 445 | -55 | $33K | -16.1% | 0.59% | EC |
| 36 | Relmada Therapeutics Inc | 75955J402 | Jul 2026 | 5,416 | NEW | $29K | — | 0.52% | EC |
| 37 | Design Therapeutics Inc | 25056L103 | Jul 2026 | 2,215 | NEW | $27K | — | 0.49% | EC |
| 38 | Regenxbio Inc | 75901B107 | Jan 2026 | 2,749 | -211 | $27K | -19.4% | 0.49% | EC |
| 39 | Oncolys Biopharma Inc | J61461109 | Jan 2026 | 1,600 | -200 | $26K | +29.7% | 0.48% | EC |
| 40 | Brainsway Ltd | 10501L106 | Jul 2026 | 1,724 | NEW | $26K | — | 0.48% | — |
| 41 | Ceribell Inc | 15678C102 | Jan 2026 | 1,447 | +29 | $26K | -12.4% | 0.47% | EC |
| 42 | NEUROGENE INC. | 64135M105 | Jan 2026 | 740 | -116 | $24K | +61.0% | 0.44% | EC |
| 43 | Clearpoint Neuro Inc | 18507C103 | Jan 2026 | 1,572 | +22 | $23K | +17.2% | 0.43% | EC |
| 44 | Benitec Biopharma Inc | 08205P209 | Jan 2026 | 1,981 | -115 | $23K | -9.1% | 0.42% | EC |
| 45 | Prothena Corporation PLC | G72800108 | Jan 2026 | 2,759 | -25 | $22K | -8.7% | 0.41% | EC |
| 46 | OVID THERAPEUTICS INC. | 690469101 | Jul 2026 | 9,777 | NEW | $22K | — | 0.40% | EC |
| 47 | MicroPort NeuroScientific Corp | N/A | Jan 2026 | 19,000 | NEW | $22K | — | 0.39% | EC |
| 48 | Neuropace Inc | 641288105 | Apr 2024 | 1,543 | -91 | $20K | -19.5% | 0.36% | EC |
| 49 | SanBio Company Limited | N/A | Jan 2026 | 3,400 | NEW | $20K | — | 0.36% | EC |
| 50 | Zylox-Tonbridge Medical Technology Co Ltd | N/A | Jan 2026 | 8,000 | NEW | $19K | — | 0.35% | EC |
| 51 | VANDA PHARMACEUTICALS INC. | 921659108 | Apr 2024 | 3,342 | -175 | $17K | -35.7% | 0.31% | EC |
| 52 | Newron Pharmaceuticals SpA | T6916C102 | Jul 2026 | 1,060 | NEW | $15K | — | 0.28% | EC |
| 53 | Anavex Life Sciences Corp | 032797300 | Apr 2024 | 5,343 | -441 | $15K | -46.0% | 0.27% | EC |
| 54 | PEIJIA MEDICAL LIMITED | G6981F109 | Jan 2026 | 28,000 | -1,000 | $14K | -41.7% | 0.26% | EC |
| 55 | Santhera Pharmaceuticals Holding AG | H7155R142 | Jul 2026 | 771 | NEW | $14K | — | 0.25% | EC |
| 56 | Inhibikase Therapeutics Inc | 45719W205 | Jul 2026 | 5,679 | NEW | $12K | — | 0.23% | EC |
| 57 | Capricor Therapeutics Inc | 14070B309 | Apr 2024 | 3,077 | +498 | $12K | -79.0% | 0.22% | EC |
| 58 | Larimar Therapeutics Inc | 517125100 | Apr 2024 | 3,008 | -315 | $11K | -2.3% | 0.21% | EC |
| 59 | TONIX PHARMACEUTICALS HOLDING CORP. | 890260839 | Jan 2026 | 953 | +198 | $10K | -26.7% | 0.17% | EC |
| 60 | Voyager Therapeutics Inc | 92915B106 | Apr 2024 | 3,080 | +286 | $9K | -14.4% | 0.17% | EC |
| 61 | Entrada Therapeutics Inc | 29384C108 | Apr 2024 | 1,328 | -62 | $9K | -43.3% | 0.16% | EC |
| 62 | AC Immune SA | H00263105 | Jul 2026 | 3,783 | NEW | $8K | — | 0.15% | EC |
| 63 | Acumen Pharmaceuticals Inc | 00509G209 | Jul 2026 | 3,768 | NEW | $8K | — | 0.15% | EC |
| 64 | Alector Inc | 014442107 | Apr 2024 | 4,762 | +400 | $7K | -12.8% | 0.13% | EC |
| 65 | Neumora Therapeutics Inc | 640979100 | Jul 2026 | 4,388 | NEW | $7K | — | 0.13% | EC |
| 66 | Myung In Pharm Co Ltd | Y6S5DX102 | Jul 2026 | 212 | NEW | $6K | — | 0.11% | EC |
| 67 | PepGen Inc | 713317105 | Jul 2026 | 3,476 | NEW | $6K | — | 0.11% | EC |
| 68 | BlackRock Funds III: BlackRock Cash Funds: Treasury; SL Agency Shares | 066922477 | Jan 2026 | 5,950 | +4,276 | $6K | +255.4% | 0.11% | STIV |
| 69 | MapLight Therapeutics Inc | 56565P103 | Jul 2026 | 445 | NEW | $6K | — | 0.11% | EC |
| 70 | Cognition Therapeutics Inc | 19243B102 | Jan 2026 | 4,543 | -842 | $4K | -31.1% | 0.07% | EC |
| 71 | HONG KONG DOLLAR | N/A | Jan 2026 | 7,547 | NEW | $962 | — | 0.02% | — |
| 72 | KOREAN WON | N/A | Jan 2026 | 819,855 | NEW | $575 | — | 0.01% | — |
| 73 | EURO | N/A | Jan 2026 | 254 | NEW | $293 | — | 0.01% | — |
| 74 | DANISH KRONER | N/A | Jan 2026 | 1,386 | NEW | $214 | — | 0.00% | — |
| 75 | SWEDISH KRONE | N/A | Jan 2026 | 1,743 | NEW | $183 | — | 0.00% | — |
| 76 | SWISS FRANC | N/A | Jan 2026 | 111 | NEW | $137 | — | 0.00% | — |
| 77 | JAPANESE YEN | N/A | Jan 2026 | 14,537 | NEW | $91 | — | 0.00% | — |
| 78 | AUSTRALIAN DOLLAR | N/A | Jan 2026 | 66 | NEW | $47 | — | 0.00% | — |
| ✕ | CATALYST PHARMACEUTICALS, INC. | 14888U101 | — | 7,110 | SOLD | $0.2M | — | — | — |
| ✕ | CENTESSA PHARMACEUTICALS PLC | 152309100 | — | 6,159 | SOLD | $0.2M | — | — | — |
| ✕ | AVADEL PHARMACEUTICALS PUBLIC LIMITED COMPANY | G29687103 | — | 5,990 | SOLD | $0.1M | — | — | — |
| ✕ | Fulcrum Therapeutics Inc | 359616109 | — | 3,080 | SOLD | $0.0M | — | — | — |
| ✕ | SANGAMO THERAPEUTICS, INC. | 800677106 | — | 21,371 | SOLD | $0.0M | — | — | — |
| ✕ | CASSAVA SCIENCES, INC. | 14817C107 | — | 2,457 | SOLD | $0.0M | — | — | — |